Diabetic Retinopathy Market – Outlook, Trends AndPredictions, 2015 To 2022

Diabetic retinopathy refers to an eye disorder that injures the retina’s blood vessels. The light-sensitive interior eye surface on which images are produced is known as the retina. Diabetes can impact the retina in the long run. This is owing to high levels of blood glucose injuring the retina’s small blood vessels. The management of diabetic retinopathy relies on the phase of the illness. It is led forward to hinder or prevent the disease from advancing further. Anti-VEGF drugs, laser surgery and vitrectomy are some of the treatments available.

For Market Research Report on “Diabetic Retinopathy Market” Visit –http://www.grandviewresearch.com/industry-analysis/diabetic-retinopathy-market


Rising diabetes cases around the world are expected to steer further demand for the diabetic retinopathy market. The worldwide market was predicted to have collected an income worth around 5, 934 million in 2014. It is projected to rise at about 6.8 percent CAGR through the forecast phase. Growing blindness cases triggered by diabetes also further the market.

The diabetic retinopathy market includes screening of the retina and choice of treatment based on how severe the condition is.Moreover, augmenting population of the elderly is also estimated to improve the applicability of the market, thus propelling the same. Financialsustainability on account of 11 percent worldwide medical expenses in the management and prevention of this illness is a primary driver for emergent regions to endorse the diabetic retinopathy market.


The various categories into which the diabetic retinopathy market is divided are treatments, kinds and geographies. The treatments market consists of intraocular steroid injections, anti-VEGF treatment, vitrectomy and laser surgery.

The market, on account of kinds, is segmented into non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. The geographies diabetic retinopathy market is fragmented on the basis of Europe, rest of the world, North America and Asia Pacific.


The treatments diabetic retinopathy market is likely to be dominated by the anti-VEGF sector. This sector is predicted to occupy the biggest share through the forecast phase. This is due to connected attributes, such as quicker recuperation and improved treatment. The kinds diabetic retinopathy market was dominated by the sector of non-proliferative diabetic retinopathy in 2014. This sector made up for the biggest share. This was on account of several patients within an illness history of less than ten years.

Growing diabetes cases, non-compliant screening of retina and falling short of exact detection are the drivers of the non-proliferative diabetic retinopathymarket sector. Proliferative diabetic retinopathy is estimated to experience profitable expansion in the future.This expansion is expected owing to the rising population of old people entering the proliferative phase of retinopathy. The geographies diabetic retinopathy market was leaded by North America in 2014. The region occupied the biggest share.

This was due to increasing diabetes cases, rising demand for the untimely diagnosis of diabetic retinopathy and favorable reimbursement amenities. Huge infiltration of anti-VEGF drugs in markets is a prime factor adding revenue to this region. The Europeandiabetic retinopathy market followed North America and produced the second biggest income. It was propelled forward by amplified consciousness among patients. The developing countries of Asia Pacific are anticipated to undergo significant expansion through the forecast phase.

This is because of the intensifying old population, growing disposable incomes and boosting research subsidies for diabetes.

Diabetic Retinopathy Market

Information Source: Grand View Research






Leave a Reply

Your email address will not be published. Required fields are marked *